Sorry, you need to enable JavaScript to visit this website.

August Social Media Round-Up—Financial Update, World Humanitarian Day, RSV Vaccine


August typically brings two things: the dog days of summer and a lot of vacations! Social media tends to be a little quieter than usual, but that doesn’t mean there wasn’t plenty of activity on the Pfizer side of things. Our CEO provided a financial update, we celebrated World Humanitarian Day, and approvals for a pair of important vaccines.

Catch up below.

CEO Albert Bourla provides an update on Pfizer’s financial performance in the 2nd quarter:

Chief Oncology Research and Development Officer Chris Boshoff shares his thoughts on Pfizer’s newly approved immunotherapy for multiple myeloma:

CEO Albert Bourla celebrates the FDA’s approval of Pfizer’s maternal RSV vaccine:

Chief People Experience Officer Payal Sahni Becher highlights August’s World Humanitarian Day:

CEO Albert Bourla takes a closer look at the recent approval of Pfizer’s maternal RSV vaccine:

Forbes’ 3rd Annual “50 over 50” list includes Pfizer’s own Sally Susman:

Lidia Fonseca, Pfizer’s Chief Information Officer, was the proud winner of a Super Global ORBIE Award recognizing the best technology leadership:

    Albert Bourla Business Leadership Vaccines
Recent Updates and Statements